Passage Bio

Janux Therapeutics

C4 Therapeutics

Allakos

Alpine Immune Sciences

SomaLogic

Ventyx Biosciences

Verve Therapeutics

Athira Pharma

Centessa Pharmaceuticals

Century Therapeutics

GH Research

Graphite Bio

Immunic Therapeutics

Immunovant

Cullinan Oncology

Dice Therapeutics

Edgewise Therapeutics

Logos Global Management, LP

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Apple Mobile Web Clips Icon

Google Font API

WordPress

LetsEncrypt

nginx

Microsoft Exchange Online

CIO & Managing Partner

Arsani William

Operations

Chris Zellner

Information Technology

Edward Zhong

Executive Assistant and Office Manager

Bonny Chen

Chief Financial Officer

Cynthia Goldsmith

Legal

Derek G.

Head of Marketing & Investor Relations

Elana Sears

Partner, Head of Research

Yanni Souroutzidis

Graham Walmsley

Co-Founder and Managing Member

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.

enGene is a biotechnology company develops treatment for mucosal diseases through inducing therapeutic proteins of harmful proteins.

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Investors Active in Asia-Pacific (APAC) (Top 10K)

Venture Capital Investors (Top 10K)

San Francisco Bay Area Early Stage Venture Investors

Investors Active in East Coast (Top 10K)

Logos Capital is a fundamental biotechnology-focused fund that seeks to combine in-house data analytics with scientific and clinical expertise to identify transformative therapies in healthcare.

Based in San Francisco, Logos combines expertise across medical, scientific, and statistical disciplines to expand the depth of diligence in identifying compelling investment ideas and uncorrelated-market returns. They combine scientific diligence with their statistical modeling of clinical trials to achieve the highest levels of conviction in each position.

Logos Opportunities Fund I LP

Logos Global Opportunities I

San Francisco

California

United States

North America

Logos Capital

Aclaris Therapeutics Announces $80 Million Private Placement

Indonesia

Asia

United Kingdom

Europe

Silversmith Capital Partners is a Boston-based growth equity firm focused on partnering with, and supporting, the best entrepreneurs in growing industries.

Silversmith Capital Partners

Core Finance is a competitor of Logos Capital in the financial services industry.

Core Finance

Stonehaven LLC is a competitor of Logos Capital in the financial services industry.

Stonehaven LLC

US Strategic Capital Inc is a competitor of Logos Capital in the financial services industry.

US Strategic Capital Inc

Axio Jensen Partners Ltd is a competitor of Logos Capital in the financial services industry.

Axio Jensen Partners Ltd

Boehringer Ingelheim Venture Fund GmbH is a competitor of Logos Capital in the biotechnology industry.

Boehringer Ingelheim Venture Fund GmbH

Revitope Oncology Inc is a competitor of Logos Capital in the biotechnology industry.

Revitope Oncology Inc

Stelexis Therapeutics LLC is a competitor of Logos Capital in the biotechnology industry.

Stelexis Therapeutics LLC

Logos Capital is a venture capital and private equity firm that specializes in providing growth capital to technology companies. The firm focuses on investments in the technology sector, particularly in software and tech-enabled services businesses that demonstrate strong growth potential and operational excellence.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 14, 2024 10:15 PM	a6dd7cf0
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	a20b14d3
crunchbase profile	general	Nov 25, 2024 9:47 AM	7ba44842
li profile	general	May 14, 2024 10:15 PM	7ce0752a
translate crunchbase fundingrounds	general	Nov 25, 2024 2:04 PM	2d22432a
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:LOGOSCAPITAL

Logos Capital